Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the influenza virus, from an infected person to household members by 32%1 ...

Author Andrew Leland Breaks Down Misconceptions of People with Disabilities; Business Leader Thomas Wlodkowski Recognized for Bolstering Access to Media; Mattel Lauded for Blind Barbie’s Global Impact ...

“No one should have to wait days—or weeks—for approval to receive needed care,” said Ganesh Padmanabhan, CEO of Autonomize AI ...

Vitamin D is another crucial component that boosts the immune system and prevents the development of insulin resistance. It ...

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, ...

The allowed claims in this patent encompass a novel dosing regimen of 200 ppm to 320 ppm gNO for 10 to 45 minutes, 2 to 5 times per day, to provide a nitric oxide-load (NO load) of 300 ppm-hrs to 900 ...

Clinical Trials in Progress: Prostate and Kidney Cancer: WATER IV Prostate Cancer: A Randomized Phase III Study of Aquablation Versus Radical Prostatectomy for the Treatment of Localized Prostate ...

In 2024, Iqirvo® received marketing approval in PBC in both the United States and Europe, and was subsequently commercially launched in the U.S. and in some European countries by Ipsen, who reported ...

About VIVO Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, ...

NurExone’s ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...

Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, today announced that it is changing its corporate name to SafeSpace Global ...

Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building, will report its financial results for the quarterly period ended March 31, 2025, after the close of the market on ...